EME Medical
EME Medical › Drug encyclopedia

💊 Adalimumab (Humira)

💊 Tumor necrosis factor (TNF) blocker – human monoclonal antibody

Adalimumab is a biologic medicine given by subcutaneous injection that blocks TNF, an inflammatory substance in the body. It is used to treat several immune-mediated inflammatory conditions such as rheumatoid arthritis, Crohn's disease, ulcerative colitis, and psoriasis. It carries a boxed warning for serious infections and malignancy, so it must be used under a doctor's supervision.

🏷️ Brands: Humira📋 Prescription only
In Arabic: أداليموماب (هيوميرا)
Chemical structure of Adalimumab
ⓘ

🏷️ Brand names & manufacturers

Humira — Cordavis LimitedHumira🏭 Cordavis LimitedDailyMed
Adalimumab-aacf — Fresenius Kabi USA, LLCAdalimumab-aacf🏭 Fresenius Kabi USA, LLCDailyMed
Packages shown are US-market (DailyMed). Brands available in Palestine are in the price section below.

✅ What it is used for

🧪 Active ingredient

The active ingredient is adalimumab, a human monoclonal antibody that binds specifically to TNF-alpha and blocks its interaction with cell surface TNF receptors, thereby reducing the inflammation associated with these conditions.

🌿 Benefits

📝 How to use

💊 Dosage forms

⚠️ Common side effects

  • Infections (e.g., upper respiratory infection, sinusitis)
  • Injection site reactions (redness, itching, bleeding, pain, or swelling)
  • Headache
  • Rash

🚨 Serious — seek medical help

  • Serious infections that may lead to hospitalization or death, including active tuberculosis, invasive fungal infections, and bacterial, viral, and other opportunistic infections
  • Malignancies including lymphoma (some fatal cases reported in children and adolescents) and hepatosplenic T-cell lymphoma
  • Anaphylaxis or serious hypersensitivity reactions
  • Hepatitis B virus reactivation
  • Demyelinating disease (new onset or exacerbation)
  • Cytopenias and pancytopenia
  • Heart failure (new onset or worsening)
  • Lupus-like syndrome or autoimmune hepatitis

⛔ Do not use if

❗ Warnings & precautions

🔄 Drug interactions

🤰 Pregnancy

Available studies do not reliably establish an association between adalimumab and major birth defects. Adalimumab is actively transferred across the placenta during the third trimester and may affect the immune response of the exposed infant. Consult your doctor before use during pregnancy or when planning pregnancy.

🍼 Breastfeeding

The lactation section was not included in the label text provided. Consult your doctor before using this medicine while breastfeeding.

🧒 Children

Safety and effectiveness are established for polyarticular JIA (age 2+), Crohn's disease (age 6+), ulcerative colitis (age 5+), hidradenitis suppurativa (age 12+), and uveitis (age 2+). They are not established in pediatric psoriatic arthritis, ankylosing spondylitis, or plaque psoriasis. Lymphoma and other malignancies, some fatal, have been reported in children, adolescents, and young adults treated with TNF blockers. Risks and benefits should be considered before giving live or live-attenuated vaccines to infants exposed in utero.

👴 Older adults

No overall difference in effectiveness was seen between patients 65 years and older and younger adults, but serious infections and malignancies were more frequent in those 65 and older. Consider benefits and risks, and monitor closely for infection or malignancy.

🌡️ Storage

Full storage details were not included in the label text provided. The product is a sterile, preservative-free solution; follow the storage instructions on the package or ask your pharmacist.

⏰ Missed dose

The label text provided gives no specific guidance on missed doses. Contact your doctor or pharmacist for advice, and do not double the dose on your own.

🆘 Overdose

Doses up to 10 mg/kg were given in clinical trials without dose-limiting toxicity. In case of overdose, monitor the patient for signs or symptoms of adverse reactions and institute symptomatic treatment immediately; consider contacting a poison control center or medical toxicologist.

💰 Price & brands in your area

🏛️ Official price in Palestine — Ministry of Health price list:

ProductCompanyPackPrice
Hyrimoz 40mg/0.8ml 2 PFP
Adalimumab 40mg/0.8ml
MASROUJI CO.2 Pre- Filled Pen2,084 ₪
HYRIMOZ 40MG/0.4ML - 2 PFP
Adalimumab
MASROUJI CO.2 PFP2,114 ₪
HYRIMOZ 40MG/0.4ML - 2 PFS
Adalimumab
MASROUJI CO.2 PFS2,114 ₪
Source: pharmacy.moh.ps · list updated: 2026-11-10

📍 Find the nearest pharmacy

Your location is used only in your browser to show nearby pharmacies — we don't store it.

Open in Google Maps

👨‍⚕️ For healthcare professionals

Mechanism of action

Adalimumab binds specifically to TNF-alpha and blocks its interaction with the p55 and p75 cell surface TNF receptors. It also lyses surface TNF-expressing cells in vitro in the presence of complement. It does not bind or inactivate lymphotoxin (TNF-beta). It modulates TNF-regulated biological responses, including adhesion molecule concentrations (ELAM-1, VCAM-1, ICAM-1). Decreases in CRP, ESR, IL-6, MMP-1, and MMP-3 were observed after treatment.

Labeled dosing

Administered by subcutaneous injection; the dose is determined by the treating physician. Adults: RA, PsA, AS 40 mg every other week (some RA patients not on methotrexate may benefit from 40 mg weekly or 80 mg every other week). Crohn's disease and ulcerative colitis: 160 mg Day 1, 80 mg Day 15, then 40 mg every other week from Day 29 (discontinue in UC if no clinical remission by Week 8/Day 57). Plaque psoriasis and uveitis: 80 mg initial dose, then 40 mg every other week starting one week later. Hidradenitis suppurativa: 160 mg Day 1, 80 mg Day 15, then 40 mg weekly or 80 mg every other week from Day 29. Pediatric dosing is weight- and indication-based.

🎓 Key points for students

🩺 Run a clinic or medical center?

EME runs your whole clinic: appointments with WhatsApp reminders, patient files, finance & inventory, a patient portal and a members-price medical store — with your data isolated and protected.

Try EME free   How we protect your data

❓ FAQ

What is adalimumab used for?

It is used to treat rheumatoid, psoriatic, and juvenile arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis, as prescribed by a doctor.

How is it given?

By subcutaneous injection using a pen or prefilled syringe; the dose is set by your doctor or pharmacist.

Does it increase the risk of infection?

Yes. It increases the risk of serious infections such as tuberculosis and fungal, bacterial, and viral infections. TB is tested for before treatment and infections are monitored during treatment.

What are the common side effects?

Infections (such as upper respiratory infection and sinusitis), injection site reactions, headache, and rash.

Can I receive vaccines during treatment?

Live vaccines should be avoided during treatment. Ask your doctor before receiving any vaccine.

Can it be used during pregnancy?

Adalimumab crosses the placenta in the third trimester and may affect the infant's immune response. Consult your doctor before use.

⚕️ For education only — not a substitute for advice from your doctor or pharmacist. Do not start or stop any medicine without advice. Source: official FDA drug label via openFDA (2025-12), simplified. Updated: 2026-11-15.